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https://doi.org/10.1016/j.cell.2021.04.039SUMMARYThehuman fetal immunesystembegins todevelopearly duringgestation; however, factors responsible for fetal
immune-priming remain elusive. We explored potential exposure to microbial agents in utero and their contri-
bution toward activation of memory T cells in fetal tissues.We profiledmicrobes across fetal organs using 16S
rRNAgene sequencing anddetected lowbut consistentmicrobial signal in fetal gut, skin, placenta, and lungs in
the 2nd trimester of gestation. We identified several live bacterial strains including Staphylococcus and Lacto-
bacillus in fetal tissues, which induced in vitro activation ofmemory T cells in fetal mesenteric lymph node, sup-
porting the role of microbial exposure in fetal immune-priming. Finally, using SEM and RNA-ISH, we visualized
discrete localization of bacteria-like structures and eubacterial-RNA within 14th weeks fetal gut lumen. These
findings indicate selective presence of live microbes in fetal organs during the 2nd trimester of gestation and
have broader implications toward the establishment of immune competency and priming before birth.INTRODUCTION
The human fetal immune system is known to develop early dur-
ing gestation with significant diversity in its immune repertoireCell 184, 1–16, J
This is an open access article undand apparent sensitivity toward external antigens (Halkias
et al., 2019; Li et al., 2019; McGovern et al., 2017; Papadopoulou
et al., 2019; Park et al., 2020; Rackaityte and Halkias, 2020; Re-
chavi et al., 2015; Schreurs et al., 2019; Stras et al., 2019; Tieppoune 24, 2021 Crown Copyright ª 2021 Published by Elsevier Inc. 1







Figure 1. Identification of T cell diversity during the 2nd trimester of human fetal development
(A) Suspension mass cytometry (CyTOF) was performed on PMA/ionomycin-stimulated fetal T cells. The UMAP projection shows all the fetal and adult organs
and blood samples used for T cell analysis: fetal gut (7), fetal lung (9), fetal liver (5), fetal skin (6), fetal thymus (8), fetal mLN (3), adult gut (5), adult lung (2), fetal (4),
cord (3), and adult blood (4). Numbers in parenthesis represent number of samples being analyzed.
(legend continued on next page)
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Articleet al., 2020; Zhang et al., 2014), thus indicating a much more
competent and diversified system than previously thought. We
have shown previously that fetal dendritic cells (DCs) promote
T cell-mediated immune suppression during early fetal develop-
ment, indicating an active and responsive immune architecture
during the 2nd trimester of gestation (McGovern et al., 2017).
However, the factors responsible for such in utero priming and
their effect on the immune system of the developing fetus remain
elusive.
Here, usingamasscytometry-basedapproach to study tissue-
specific human fetal T cells across multiple organs, we identified
cytotoxic T cells andmost notably effectormemory T cells (Tems)
across the 2nd trimester of gestation, in addition to regulatory
T cells (Tregs). Tregs are known to be essential for the regulation
of commensal microbe-specific effector and memory responses
duringhomeostasis (Kuczmaet al., 2020; Leechet al., 2019;Mold
et al., 2010; Nutsch et al., 2016; Russler-Germain et al., 2017).
Several studies have recently detected microbe traces in human
placenta and fetal samples (Aagaard et al., 2014; Al Alam et al.,
2020; Ardissone et al., 2014; Biasucci et al., 2008; Cao et al.,
2014; Collado et al., 2016; Funkhouser and Bordenstein, 2013;
de Goffau et al., 2019; Diaz Heijtz, 2016; Jiménez et al., 2005;
Kundu et al., 2017; Parnell et al., 2017; Perez-Muñoz et al.,
2017; Rackaityte et al., 2020; Romano-Keeler and Weitkamp,
2015; Seferovic et al., 2019; Stout et al., 2013; Willyard, 2018;
Younge et al., 2019). However, activemicrobial presence in utero
is still a topic of constant debate, and novel sensitive approaches
are required to understand the complexities of human gestation
(Collado et al., 2016; Fricke and Ravel, 2021; Perez-Muñoz
et al., 2017; Robertson et al., 2019; Senn et al., 2020; Silverstein
andMysorekar, 2021; Stinson et al., 2019). Thus, we explored the
presence of microbes in fetal tissues and their potential role in
priming and activation of memory T cells during fetal develop-
ment. Using 16S rRNA gene sequencing approach, we detected
a low but consistent microbial signal across several fetal tissues
in the 2nd trimester of gestation with a significant increase in bac-
terial diversity compared to PBS controls. Sequencing results
were validatedbyaerobic andanaerobic culturingof fetal tissues,
followed by isolation and identification of several live bacterial
strains. To visualize the bacteria in fetal tissues, we performed
scanning electron microscopy (SEM) and RNA-in situ hybridiza-
tion (RNA-ISH) and identified differentially located bacteria within(B) UMAP projection of all the blood samples, along with individual projections of
adult blood (4).
(C) UMAP projection of the T cells from fetal and adult organs, along with individua
(5), fetal skin (6), fetal thymus (8), fetal mLN (3), adult gut (5), and adult lung (2).
(D) UMAP projection of fetal versus adult organs (in orange and blue, respectively).
both fetal and adult tissues. Tregs in CD4 compartment is also shown based on
(E) UMAP feature projection of T cell markers (CD3, CD4, and CD8) and Treg-as
panels, respectively.
(F) Percentage of Tregs in fetal versus adult tissues and in blood samples (fetal, a
strategy and reference plots in Figures S1B and S1C). As shown, Tregs are enric
(G) TNF cytokine expression in CD4+ (top) andCD8+ (bottom) T cells as determined
reference plots in Figure S1G).
(H) Percentage of CD4+ (top) and CD8+ (bottom) CD45RO+memory T cells in fetal
in Figure S1I).
(I) Percentage of TNF+ cells in CD4+ (top) and CD8+ (bottom) CD45RO+ effector
See also Table S1.the fetal intestinal lumen. Notably, fetal-isolated bacterial strains
induced memory T cell activation and expansion of fetal lymph
node T cells, thereby indicating a previous encounter andpriming
of fetal immune system with bacterial antigens. Altogether, our
observations suggest a sparsemicrobial presence in fetal tissues
and their potential priming of the fetal immune system, thereby
leaving the footprints of microbial memory during early develop-
ment. These findingshavebroad implications for our understand-
ing of humandevelopment and the establishment of a competent
and diverse immunity before birth.
RESULTS
T cell pool during the 2nd trimester of human fetal
development is diverse and competent
To study the fetal immune system and its microbial components,
we established a careful protocol for collection and processing
of fetal tissues (see STAR Methods for detailed collection and
processing protocol) (McGovern et al., 2017). The study is
divided into four stages: T cell profiling by mass cytometry (Cy-
TOF), 16S rRNA gene sequencing for bacterial identification, cul-
ture-based sequencing of live fetal bacteria, and in vitro T cell
proliferation assay to demonstrate microbial immune recognition
(Figure S1A). The samples collected were split between different
arms of the study depending on the sample conditions and
resource availability (Table S1).
We first profiled T cells from fetal lung, skin, gut, thymus, liver,
mesenteric lymph nodes (mLN), and blood by using state-of-the-
art CyTOF approach as recently described (Yeo et al., 2020)
(antibody list in the Key resources table). Fetal spleens were
not sufficiently large enough to use for both T cell analysis and
bacterial DNA sequencing; hence, they were excluded from
T cell profiling. Unsupervised uniform manifold approximation
and projection (UMAP) analysis (Becht et al., 2018) of T cells
from fetal (13–23 weeks estimated gestational age [EGA]) and
adult samples revealed that fetal, adult, and cord blood clustered
together at one end of the UMAP, whereas the fetal and adult or-
gans formed two distinctly separate clusters (Figure 1A). This
suggests organ-specific priming of T cells during the 2nd
trimester of gestation. A small fraction of non-T cells were also
present, which were removed from further analysis. We next
separated all blood samples from tissues followed byeach sample type (fetal, cord, and adult blood): fetal blood (4), cord blood (3),
l projections of each organ over the UMAP: fetal gut (7), fetal lung (9), fetal liver
CD4+ andCD8+ T cell clustering is also shown on the sameUMAPprojection, in
CD4+CD25+FOXP3+CD152+ markers.
sociated markers (CD25, FOXP3, and CD152) are shown on top and bottom
dult, and cord blood) as determined by mass cytometry analysis (input gating
hed in fetal organs as compared to adult organs and blood.
bymass cytometry analysis of fetal and adult tissues (input gating strategy and
and adult tissues and blood samples (input gating strategy and reference plots
memory T (Tem) cells in fetal and adult tissues and blood samples.
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Articleindependent UMAP analysis for both datasets. The unsuper-
vised clustering of all blood T cells further showed no distinct
separation among fetal, adult, and cord blood samples based
on our panel ofmarkers (Figure 1B). However, the tissues consis-
tently showed distinct separation between fetal and adult organs
in UMAP analysis (Figure 1C).
We identified fetal- and adult-specific CD4+ and CD8+ T cells
based on the marker projections as well as CD4+FOXP3+CD
25+CTLA4+ Tregs, which formed distinct clusters for both fetal
and adult organs (Figures 1D and 1E). The tight clustering of
Treg populations from a range of fetal tissues indicates that
Tregs have a conserved phenotype across organs. We observed
a remarkable enrichment of Tregs in fetal tissues in comparison
to adult organs (Figure 1F, Treg input gating strategy and refer-
ence plots in Figures S1B and S1C). Interestingly, fetal tissue
Tregs were highly enriched for PD1+Ki67+ expression (Fig-
ure S1D), indicative of chronic TCR activation, active prolifera-
tion, and immune tolerance (Asano et al., 2017; Leung et al.,
2018; Santegoets et al., 2014; Sharpe and Pauken, 2018). We
also observed a consistent presence of CD8+Tbet+GB+ (gran-
zyme B) cytotoxic T lymphocytes (CTL) in fetal tissues that
were significantly enriched in fetal skin, lung, and liver (reference
plots and quantification in Figures S1E and S1F).
Functional immune cells with potential antimicrobial activity
and effector/memory phenotype have been demonstrated in
fetal tissues (Haynes et al., 1988; Kumar et al., 2018; Li et al.,
2018; Mackay and Gebhardt, 2013; McGovern et al., 2017;
Schuster et al., 2009; Vermijlen et al., 2010). Thus, we probed
our data for the expression of antimicrobial cytokines in CD4+
and CD8+ T cells (input gating strategy in Figure S1G). Notably,
significant expression of tumor necrosis factor (TNF+) and inter-
feron (IFN)g+ T cells were observed across fetal tissues that were
consistent among donors and tissue types (Figures 1G and S1H).
We next explored the fetal T cell memory populations (CD4+/
CD8+ and CD45RO+ T cells) across all 2nd trimester fetal tissues.
Interestingly, we observed a significant proportion of CD4+ and
CD8+ memory T cells in fetal tissues, especially in thymus (Fig-
ures 1H, S1I, and S1J). Fetal organs like gut, mLN, lung, skin,
and liver also had significantly high levels of memory T cells.
We also observed the presence of TNF+ and IFNg+ effector
Tems in fetal tissues (Figures 1I and S1J). Importantly, the
effector memory phenotype was observed in all fetal organs
except thymus despite having significant memory T cells (Fig-
ures 1H and 1I). Together, these data indicate the presence of
antigenic stimuli that drive the generation of activated T cells
within the fetal organs.
Identification of bacterial genera that colonize fetal
tissues
Recent studies have explored the presence of microbes or mi-
crobial DNA in the placenta, amniotic fluid, meconium, fetal
lung, and fetal intestine (Aagaard et al., 2014; Al Alam et al.,
2020; Ardissone et al., 2014; Biasucci et al., 2008; Cao et al.,
2014; Chen et al., 2017; Collado et al., 2016; Funkhouser and
Bordenstein, 2013; de Goffau et al., 2019; Diaz Heijtz, 2016;
Hu et al., 2013; Jiménez et al., 2005; Kundu et al., 2017; Perez-
Muñoz et al., 2017; Rackaityte et al., 2020; Romano-Keeler
and Weitkamp, 2015; Willyard, 2018). However, the presence4 Cell 184, 1–16, June 24, 2021of live microbes in human fetus still remains debated. Our search
for the potential stimuli at the source of the diverse immune
response observed in fetal tissues led us to explore the presence
of microbes in fetal tissues. Previously, we have shown that the
human fetus has an active and responsive immune architecture
during the 2nd trimester of gestation (McGovern et al., 2017);
hence this period was chosen for microbial investigation. We
profiled multiple fetal organs, including gut, skin, lung, thymus,
spleen, and placenta for the presence of bacterial signals using
high-throughput 16S rRNA gene sequencing (sample informa-
tion in Table S1 and primer sequences in Table S2). Given the
high vulnerability for contaminations in such studies, and the
new benchmarks introduced to account for reagent-associated
contaminating microbes (de Goffau et al., 2018; Knight et al.,
2018), we devised a stringent array of controls associated with
each step in the workflow, ranging from tissue procurement to
the sequencing run (Figures S2A and S2B). The controls taken
in this study can be divided into four major categories: operator
controls (hand-swabs taken from operators who have handled,
dissected, and further processed the fetal samples); environ-
ment controls (swabs taken from all the surfaces that fetal tis-
sues may have been exposed like work bench, PCR hood,
etc.); PBS controls (fetus-matched buffers for each donor, and
have undergone the same laboratory treatments as the fetal
samples, from collection to sequencing); and reagent controls
(including the molecular reagents used during DNA extraction
and sequencing process such as elution buffer, McrBc reagent,
etc.), which allowed us to monitor the contaminations present in
extraction kits and accompanying reagents. All these controls al-
lowed us to detect the contaminations introduced during organ
collection and processing as well as by the reagents used in
the process. We have also taken great care to reduce experi-
mental bias and cross-contaminations by processing all sam-
ples in isolation, in a low-contaminant, controlled environment.
Using the 16S rRNA gene sequencing data, we compared the
overall microbial diversity between different fetal organs and
their matched negative controls using weighted UniFrac dis-
tance matrices. The results of the b-diversity (diversity between
fetal samples) were visualized by a principal coordinate analysis
(PCoA) (Figure 2A). While negative control samples (PBS) mostly
clustered on one end of the PCoA plot, fetal skin and placenta
samples clustered on the opposite end, with few residing in-be-
tween. Fetal gut and lung samples were mostly dispersed be-
tween PBS and skin clusters, suggesting varying degrees of mi-
crobial diversity across tissues. PCoA plot annotated by early
(<16 weeks) and late (R16 weeks) fetal EGA across samples
projected an unbiased generalized distribution across EGA,
with no significant difference in early versus late gestational sam-
ples, when compared with matched PBS for bacterial diversity
(Figures S2C and S2D). Most importantly, BactQuant (Liu
et al., 2012) qPCR analysis across samples showed a significant
increase in bacterial DNA in fetal tissues in comparison to the
controls (PBS, reagents, and environmental controls) (Figure 2B).
CT (cycle threshold) value represents the number of cycles
required to amplify a threshold DNA signal, thereby lower CT
value corresponds to higher content of starting DNAbeing ampli-
fied. Notably, this trend was consistent across tissues, with a
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Articlewhen compared to PBS (Figure 2C) as an external control and
fetal thymus as an internal control (Figure S2E). Consistent
with this, a significant subset of fetal tissues displayed a
within-sample microbial diversity (a-diversity) that was higher
than the negative controls (Figures 2D, S2F, and S2G). More-
over, fetal tissue samples were significantly more dissimilar to
their matched PBS controls (b-diversity) than the PBS samples
were to each other (Figures 2E and S2H). The later result, in
particular, was also reproduced in an independent set of fetal
samples (Figures 2E and S2H), analyzed at a separate facility
(Weizmann Institute of Science [WIS]) using dedicated experi-
mental and analytical protocols tailored for low biomass micro-
biome studies (Geller et al., 2017; Nejman et al., 2020). Interest-
ingly, we also noted a gradual increase in bacterial diversity in
fetal tissues fromexternal or surface-exposed organs in compar-
ison to internal tissues (Figures 2F, S2I and S2J; 16S rRNA gene
sequencing sample description and extended operational taxo-
nomic units [OTU] information, in Table S3, sequencing reads for
samples at separate facility [WIS] are in Table S4). These obser-
vations also corroborate with our findings of TNF+ T cells (Figures
1G and 1I) and cytotoxic CD8+ T cells (Figures S1F, S1H, and
S1J) being more abundant within fetal skin than other organs.
Together, these findings indicate the presence of an above-
backgroundmicrobial signal in at least some of the analyzed fetal
tissues, albeit in very low abundance.
Despite having an extensive array of controls, we are aware
that contaminations may still occur; hence we attempted to
compare the bacterial taxa present in control samples to those
in fetal tissues. We analyzed our 16S rRNA gene sequencing
data based on its operational taxonomic classification using
the SILVA (v.123) database (Quast et al., 2013). We identified
the specific OTU associated with bacterial genera present in
each sample (Figure 2G). Showing the average abundance of
dominant bacterial taxa identified in PBS versus those in fetal tis-
sues, our analysis highlighted the enrichment of 7 bacterialFigure 2. High-throughput 16S rRNA gene sequencing of fetal tissues
(A) Principal coordinate (PC) analysis based onweighted UniFrac distance to the P
axis. Each sample depicted by color and numbers in parenthesis indicate samp
function of vegan (v2.5.7) package in R).
(B) Comparisons of bacterial 16S rRNA gene detection using qPCR. Comparison
plotted to determine the extent of bacterial DNA present in each sample. Unpair
(C) Comparison of CT values for each fetal organ against its PBS negative contro
significant.
(D) Fraction of samples above and below the 95th percentile of Shannon indices
against PBS controls (PBS, n = 42; reagents control, n = 10; environment, n = 55
indices prediction see Figures S2F and S2G.
(E) Weighted UniFrac distances between all PBS controls or between fetal tissu
independent microbiome sequencing and analysis protocols: SIgN (Singapore Im
Whitney test: **p < 0.005; ****p < 0.0001. ns, not significant.
(F) Weighted UniFrac distances of fetal tissues against their matched PBS contr
tances were normalized within fetus by dividing each value by the average weigh
Mann-Whitney test: *p < 0.05; **p < 0.005, ***p < 0.0005.
(G) Dot-plot showing the distribution of bacterial genera as identified by OTUs acr
are depicted as ‘‘PBS-enriched taxa’’ (orange, potential contaminants). Bacterial g
as ‘‘fetal-enriched taxa’’ (green, potential signals). Mean signal intensity of each ge
Python libraries. The samples are arranged in descending order of their signal st
(H) Relative abundance plot showing the significantly enriched taxa (log2FC >2) in
(external control). Each sphere represents differential taxa and the size of the sp
See also Tables S1, S2, S3, and S4.
6 Cell 184, 1–16, June 24, 2021genera specifically enriched in fetal samples (denoted as
‘‘fetal-enriched taxa’’ in green), including Flavobacterium, Lacto-
bacillus, Staphylococcus, Afipia, Pseudomonas, Bradyrhi-
zobium, and Brevundimonas. We also identified 7 bacterial
genera enriched in PBS and other controls (operator, reagent,
and environmental controls; denoted as ‘‘PBS-enriched taxa’’
in orange) including Ralstonia, Brevibacterium, Burkholderia,
Azospira, Nitrosomonadaceae, Sphingomonadaceae, and
Micrococcus (Figure 2G; Table S3 showing the OTU information
for each sample). Interestingly, each one of the fetal-enriched
genera showed a heterogeneous distribution among tissues,
suggesting a true signal coming from specific organs. On the
contrary, the PBS-enriched genera showed a more homoge-
neous distribution across samples in both controls and tissues
indicative of a systemic contamination. In addition, our compar-
ative analysis of bacterial enrichment in fetal gut samples in com-
parison to fetal spleen (or thymus) versus PBS control showed
similar pattern with 22 significantly enriched taxa in fetal gut
(Figures 2H and S2K). These observations suggest significant
enrichment of bacterial signals in fetal organs, more notably in
fetal gut.
Bacteria from freshly harvested fetal samples are viable
and can be cultured
To determine if these DNA signatures were predictive of the
presence of live bacteria, we inoculated tissue biopsies of freshly
harvested fetal organs (from a separate cohort of 8 fetuses D1–
D8 shown in Tables S1 and S3) in pre-reduced anaerobic blood-
supplemented basal media under anaerobic conditions and
plated the cultures under either aerobic or anaerobic conditions
(Figure 3A; see STARMethods for details). Several negative con-
trols were included in each of these experiments, including PBS
samples used at the hospital to clean surgical equipment during
fetal dissection and PBS samples used in the laboratory to clean
tools used during biopsy. None of these associated controlsand bacterial genera identification
BS. The percentage of variance explained by the PC’s is indicated next to each
les analyzed. (PERMANOVA R2 = 0.17741; p = 0.0009; analyzed using adonis
of CT (cycle threshold) values is shown along the y axis for each sample type
ed Mann-Whitney test: ****p < 0.0001. ns, not significant.
l. Unpaired Mann-Whitney test: *p < 0.05; **p < 0.005; ****p < 0.0001. ns, not
in all PBS controls. A Fisher’s exact test was performed for each sample type
; fetal tissues, n = 169). *p < 0.05. ns, not significant. For reference to Shannon
es and their matched PBS controls, across two research facilities using two
munology Network) and WIS (Weizmann Institute of Science). Unpaired Mann-
ols. Analysis was restricted to fetuses with data available for R2 tissues. Dis-
ted UniFrac distance within each fetus to determine b-diversity metric. Paired
oss all sample types. Bacterial genera high in PBS and low or equal in samples
enera that were absent or very low in PBS and high in fetal tissues are denoted
nus was calculated and plotted usingmatplotlib (v.3.2.1) and seaborn (v.0.9.0)
rength in fetal gut.
fetal gut as compared to fetal spleen (internal control) and control PBS samples





Figure 3. Culture and isolation of live bacte-
ria from freshly harvested fetal samples
(A) Schematic representation for anaerobic
culturing of fetal bacteria, followed by colony se-
lection, PCR, and Sanger sequencing of the iso-
lates.
(B) Plate images of serially diluted cultures of
fetus-matched tissue inoculates (D4 donor).
Negative controls include PBS samples used at
hospitals to clean surgical equipment during har-
vesting and tissue dissection (PBS-Hospital) and
PBS samples used in the laboratory to clean tools
used during tissue biopsy (PBS-Lab).
(C) Number of unique bacteria species identified
from each fetal tissue inoculate. Data is combined
from plates incubated under aerobic and anaer-
obic conditions. The proportion of aerobes,
facultative anaerobes, and obligate anaerobes
was determined from available literature.
(D) Dot-plots representing the bacterial genera
isolated and identified from fetal samples and their
prevalence across fetuses and tissues. Colored
dots next to the names of each genus indicate the
oxygen requirement of known species with that
genus (color coding same as in C). Multiple dots
reflect variability within the genus with respect to
their oxygen requirements. The orange star at the
right side of the plot represents the bacterial
genera that were identified by both pre-culture
and post-culture sequencing for the same tissues
(for reference see Figure S3D).
See also Tables S1, S2, S3, S5, and S6.
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Articleproduced detectable colonies for any of the 8 distinct fetuses
(Figures 3B, S3A, and S3B). In contrast, most of the cultured fetal
tissues (6 out of 8 fetal donors) produced microbial colonies
under both aerobic and anaerobic conditions (Figure S3B). Inde-
pendent cultures and plating experiments produced reproduc-
ible numbers of colonies (Figure S3C). Moreover, we observed
that plates carrying lung isolates appeared more oxidized,
potentially reflecting a higher hemolytic ability of lung-associated
bacteria. We also observed that the bacterial colony morphol-
ogies and sizes varied among different tissues suggesting a bac-
terial heterogeneity across organs. The absence of microbial
growth from the negative controls and the apparent phenotypic
differences in bacterial colonies across tissues are against the
possibility of a common contamination by a single or few exog-
enous bacterial species. We next isolated and purified several
colonies per inoculate and identified the bacterial genus via col-
ony PCR and standard 16S sequencing (Figure 3C). Consistent
with our high-throughput 16S sequencing results, a higher num-
ber of unique bacterial genera were identified in placenta or skin
than in lung or gut samples and were further reduced in the
spleen and thymus, consistent with a decreasing gradient of mi-
crobial diversity from external or surface-exposed fetal organs to
internal organs (Figures 3C, S3B, and S3C). A large fraction of theisolated species is reported as facultative
anaerobes or obligate anaerobes (Fig-
ures 3C, S3B, and S3C; Table S5). This
is an interesting observation, becausethe oxygen supply to the fetus is reported to be dependent on
the partial oxygen pressure gradient between maternal blood
and fetal organs, which is low in early gestation and increases
gradually along the gestational timeline (Gitto et al., 2002;
Torres-Cuevas et al., 2017). We next surveyed the prevalence
of bacterial genera across donors and fetal organs (Figure 3D).
Although Gardnerella, Lactobacillus, and Staphylococcus were
isolated from most of the fetal organs, other commonly isolated
genera included Streptococcus, Enterococcus, and Prevotella.
Importantly, we observed several bacterial genera, which were
both strict anaerobes and are not previously reported as vaginal
or skin commensals, such as Bifidobacterium spp., Collinsella
aerofaciens, or Clostridium hathewayi (re-classified as Hunga-
tella Hathewayi) (Kaur et al., 2014; Table S6 shows number of tis-
sues positive for the given bacteria and number of colonies iso-
lated for the given bacteria across 8 fetal donors). Interestingly,
many of these cultivatable bacteria were also found in our 16S
rRNA gene sequencing data (Figure 2G), where Lactobacillus
and Staphylococcus were among the top fetal-enriched taxa
whereas Micrococcus and Burkholderia were among the top
PBS-enriched taxa.
To address the possibility of contamination during culturing,
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Articleculturing from 7 of the 8 donors, using high-throughput 16S rRNA
gene sequencing. While matching this pre-culture sequencing
data with the culture-based sequencing results from the same
biopsies, we successfully identified 24 out of 27 distinct bacterial
genera (by their respective OTU) (Figure S3D) that were enriched
in both datasets (Figure 3D, orange stars represent matching 24
genera present in both pre- and post-culture sequencing data).
Notably, Lactobacillus, Staphylococcus, Streptococcus, Entero-
coccus,Bifidobacterium, Prevotella, and Finegoldiawere among
the ones identified by both pre- and post-culture sequencing,
hence denoting a true signal from fetal tissues, and are not intro-
duced due to culturing (Table S3 contains the extended sample
and OTU information for the given 7 fetal donors used in Fig-
ure S3D). We also observed that a majority of these bacteria
were either absent or very low in PBS samples when compared
to the fetal organs. In contrast,Micrococcus, a potential contam-
inant that was consistently present in all samples including con-
trol PBS in our data, was recently reported to be present in fetal
intestine in utero (Rackaityte et al., 2020). Similarly, Strepto-
coccus that we isolated in our culture-based method has also
been previously associated with human placental tissues,
although it is speculated that it might be as a result of a potential
infection (de Goffau et al., 2019). Therefore, the notion of true
fetal-specific bacteria still remains open and demands further
investigation. Taken together, our results reveal a sparse micro-
bial presence in certain fetal tissues, some of which can be prop-
agated by anaerobic culturing. However, their abundance in
specific fetal tissues and their prevalence across gestational
timeline still remains debatable and an area of active exploration.
Neverthelss, these results indicate a transient presence of mi-
crobial entities within fetal tissues, which may remain in a con-
stant flux, hence reflective of a snapshot in time.
Bacteria-like morphologies and eubacterial RNA can be
visualized in fetal gut lumen
To investigate the direct presence of bacteria in fetal tissues, we
performed SEM on freshly isolated fetal intestine (n = 4 indepen-
dent fetal gut samples), specifically the region around the ileum,
shown to have themost diverse and richmicrobiota within the in-
testinal tract (Dieterich et al., 2018; James et al., 2020; Rackai-
tyte et al., 2020). The environmental contamination was mini-
mized by performing sample isolation and processing underFigure 4. Visualization of bacterial structures in fetal gut lumen using
(A) Representative SEM images of 14-weeks EGA fetal mid-gut from three individ
devoid of bacteria (right) in low and high magnification images. One 10-weeks
structures. Red arrowheads indicate bacteria-like structures within the intestinal lu
14-weeks EGA fetal mid-gut lumens. Scale bars, 10 mm for low magnified views
(B) SEM images of cultured bacteria (isolated from 18-weeks EGA fetal gut) at
prominently seen with an average size of 1 mm. Scale bar, 1 mm.
(C) Representative RNA-in situ hybridization (RNA-ISH) images of fetal gut lumen d
eukaryotic epithelial cell marker Epcam-specific RNA probe in white. Image on th
visualize the bacterial RNA along-side epithelial boundaries within the lumen of f
(D) Bar plot representation of EuBac 16S rRNA and Epcam signal quantification
samples were taken as controls.
(E) Bar plot representation of EuBac 16S rRNA signal quantification in fetal mid-g
16S rRNA found in fetal gut lumen (n = 3). Statistical significance between experi
0.0001, ***p < 0.001, **p < 0.01).
See also Figure S4.sterile conditions as discussed above (Figures S2A and S2B),
and the dissected regions were fixed immediately with 2.5%
glutaraldehyde. Interestingly, we observed bacteria-like
morphological structures, resembling bacterial cocci, clustered
together within limited regions across fetal gut at the 14th weeks
of gestation (n = 3) (Figure 4A). Such bacterial cocci were
observed with an average size of 1–2 mm and were specifically
nested within mucin-like structures present along the intestinal
lumen, which were speckled across the ileum. Three of the
four samples were from 14-weeks EGA fetuses and showed a
similar bacterial localization pattern, whereas the fourth sample,
belonging to a 10-weeks EGA fetus, did not show any significant
bacterial localization across the ileum (Figure 4A). Most regions
did not show any bacterial localization, and notably, these areas
were also devoid of mucin-like structures (Figure 4A). Multiple
scans across different regions showed similar localization pat-
terns and morphologies in all three 14-weeks EGA fetuses,
with discrete bacterial structures closely packed within meco-
nium-associated mucin-like threads (Figure S4A). For one of
the 14-weeks samples, we also scanned the upper (fore-gut)
and lower (hind-gut) regions and observed similar bacterial en-
tities albeit at a lower frequency compared to the ileum (Fig-
ure S4B). These observations revealed discrete clusters of bac-
terial structures present in fetal gut, consistent with the bacterial
cocci-specific morphological embedding within meconium-
associated mucin-like structures. We also performed SEM on
the culture isolates from fetal gut and lung, wherein we observed
distinct cocci-like bacteria, further suggesting that these fetal
gut-associated bacteria are alive and can be propagated further
(Figures 4B and S4C).
To further complement these morphological observations, we
performed RNA-ISH using a eubacteria-specific 16S rRNA
probe. Interestingly, we observed distinct localization of bacte-
rial RNA, tightly packed alongside intestinal epithelium (Epcam+)
within the fetal gut lumen (Figure 4C, H&E staining image of fetal
gut cross-section in Figure S4D). Notably, these bacteria were
not observed on the stromal side of the intestine and were spe-
cifically present within the luminal cavity. The bacterial rRNA
signal was absent in corresponding fetal liver and mesenteric
lymph node (mLN) samples (Figures S4E and S4F). Quantifica-
tion of the bacterial signal (with respect to DAPI staining) showed
significant enrichment of eubacterial 16S rRNA in fetal gut asSEM and RNA-ISH
ual fetal samples (n = 3) showing the mucosal area with bacteria (left) and area
EGA fetal mid-gut lumen is also shown below with no detectable bacterial
men. Cocci-like bacteria were seen with an average size of 1 mm in all the three
and 1 mm for high magnified views.
tached on the nitrocellulose membrane. Cocci-like bacterial structures were
emonstrating the pan-bacterial probe against bacterial 16S rRNA in green and
e right shows merged file and the image in inset represents zoomed-in view to
etal intestine (mid-gut). Scale bar, 40 mm.
with respect to DAPI signal at 100% saturation (n = 3). The fetal liver and mLN
ut lumen beside fetal liver and mLN samples. Significant detection of bacterial
mental groups was determined by two-tailed, unpaired Student’s t test (****p <
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Articlecompared to fetal liver and mLN (n = 3) (Figures 4D and 4E).
Taken together, these observations demonstrate direct pres-
ence of bacteria within the fetal gut lumen during the 2nd
trimester of gestation.
Fetal bacteria prime syngeneic T cells and induce
expansion and memory activation of fetal T cells
Our data demonstrate the presence of specific bacterial signals
across fetal organs, specifically the fetal gut, although it is not
clear what the physiological significance of these microbes
could be. The effect of microbe-derived signals on the priming
and maturation of the postnatal immune system in general is
quite well established (Belkaid and Hand, 2014; Chung et al.,
2012). Hence, we hypothesized that fetal microbial antigens
could be one of the active forces behind the diverse T cell re-
sponses observed in fetal tissues. We thus proceeded to explore
their potential cross-talk with the fetal immune system.
Commensal microbes are known to elicit tissue-specific T cell
memory responses, which get activated upon any potential
breach in mucosal barrier (Belkaid and Tarbell, 2009; Belkaid
et al., 2013; Hand et al., 2012; Harrison et al., 2019; Hegazy
et al., 2017; Homann et al., 2001; Linehan et al., 2018; Schreurs
et al., 2019; Sorini et al., 2018;Whibley et al., 2019). In the case of
the gut, it is proposed that the microbe-specific memory T cells
reside in the gut-associated mLN (Belkaid et al., 2013). In adult
mice, microbial antigen-laden DCs are known to migrate to
mLN thereby inducing microbe-specific T cell expansion (Bel-
kaid et al., 2013; Hand et al., 2012; Leech et al., 2019; Linehan
et al., 2018). We have previously shown that human fetal DCs
migrate to the fetal mLN as early as the 16th weeks of gestation
(McGovern et al., 2017) and thus hypothesized that these migra-
tory DCs may expose the T cells in fetal mLN to microbial anti-
gens and prime them against microbial entities within fetal tis-
sues. To test if fetal T cells could be recalled by DC presenting
fetal bacteria-derived antigens, we recapitulated a minimalistic
fetal environment in vitro with an autologous T cell expansion
and activation assay (Figure 5A). We first sorted HLA-DR+ DCs
and T cells from the same fetal mLN (Figure 5B). T cells were pu-Figure 5. Syngeneic T cell expansion and memory activation assay for
(A) Schematic representation of the syngeneic T cell expansion assay. DCs iso
presented to CTV-labeled T cells from the same organ (mLN). At day 6, T cell ex
(B) Sort profile of fetal DCs and T cells for T cell expansion assay. HLA-DR high a
enriched for CD14-negative cells. T cells were sorted by negative selection by gati
of T cells, a small portion was assayed by post-sort for T cell profile and found t
(C) Representative flow cytometry plots for T cell expansion (16 weeks EGA fetal
Lactobacilli)-primed DCs for 6 days. For controls, T cells were incubated with u
control, respectively. T cell expansion is assayed by measuring dye dilution using
DCs primed with fetal Staphylococci (blue), T cells + DCs primed with fetal Lacto
T cell profile at day 0 is shown at the left.
(D) Total T cell number (absolute count) as counted by CountBright beads and m
significance between experimental groups was determined by paired t test (****p
(E) CD45RO+ memory T cell expansion post 6 day incubation measured by CD45
T cell + DCs alone (gray). For comparisons, T cell at day zero is shown at the lef
(F) Frequency of CTVneg expanded memory T cells (CD45RO+, CTVneg) plotted fo
(G) CD69+ activatedmemory T cell expansion post 6 day incubation measured by
to T cell + DCs alone (gray). For comparisons, T cell at day 0 is shown at the left
(H) Frequency of expandedCD69+ active memory T cells (CTVneg) plotted for all co
by two-tailed, unpaired Student’s t test (****p < 0.0001, ***p < 0.001, **p < 0.01).
See also Figure S5.rified by negative selection tominimize activation, followed by la-
beling with a fluorescent dye CellTrace violet (CTV), prior to bac-
terial exposure. Sorted DCs were incubated with heat-killed fetal
Lactobacilli or fetal Staphylococci for 8 h prior to coculture with
T cells. These two bacteria were chosen because they were
consistently present in fetal tissues in both high-throughput
16S rRNA gene sequencing and culture-based methods. Bacte-
ria primed DCs were then presented to fetal T cells and their
expansion was monitored post 6 days of incubation. For nega-
tive control, un-primed DCs (DCs alone, no bacteria) were incu-
bated with T cells and CD3/28 Dynabeads were used for positive
control. Fetal Staphylococci antigen-exposed T cells showed an
average 70% (±15%) memory expansion, whereas the lactoba-
cilli-exposed T cells showed 55% (±13%) memory expansion,
in comparison to unprimed DC control (Figure 5C, input gating
strategy and representative flow cytometry plots in Figures
S5A–S5E). Upon exposure with fetal bacteria primed DCs, we
observed a significant increase in total T cell count, demon-
strating the expansion of T cells post bacterial priming (Fig-
ure 5D). Notably, the magnitude of T cell expansion with Staph-
ylococci-primed DCs was consistently higher than with
Lactobacilli, suggesting a bacteria specific heterogeneity in fetal
T cell responses. Positive control (CD3/28 Dynabeads) showed
more than 95% expansion throughout. Assessment of TNF
and IFNg production post 6 day bacterial exposure in culture su-
pernatants revealed that both TNF and IFNg were abundantly
produced and released upon fetal Staphylococci exposure (Fig-
ures S5F and S5G). Interestingly, we observed a significant in-
crease in CD45RO expression post expansion, indicating a po-
tential memory phenotype against microbial antigens, whereas
only <12% of memory T cells (CD45RO+) were present at day
0 prior to exposure (Figures 5E and 5F). Interestingly, there
was a significant increase in the activation and tissue residency
marker CD69 (50% versus 1% on day 0) post-expansion, sug-
gesting the early stages of memory activation upon bacterial
exposure (Figures 5G and 5H).
Next, we aimed to investigate if the effect on T cell activation
observed post bacterial exposure is specific to antigenfetal T cells primed with fetal bacteria
lated from fetal mLN were primed with heat-killed fetal bacteria (for 8 h) and
pansion is assayed by dye dilution using flow cytometry.
nd lineage negative cells were selected for DC population, which were further
ng on lineage-negative andHLA-DR-negative cells. Further, to assess the purity
o be more than 75% pure.
mLN). CTV-labeled T cells were incubated with bacteria (fetal Staphylococci or
nprimed DCs (no bacteria) or CD3/28 Dynabeads as a negative and positive
flow cytometry. The conditions shown are T cells + DCs alone (gray), T cells +
bacilli (green), and T cells + CD3/28 Dynabeads (magenta). For comparisons,
anually, post 6 day incubation, plotted for all the conditions (n = 4). Statistical
< 0.0001, ***p < 0.001, **p < 0.01).
RO expression and dye dilution (CTVneg) for all the conditions in comparison to
t.
r all conditions.
CD69 expression and dye dilution (CTVneg) for all the conditions, in comparison
.
nditions. Statistical significance between experimental groups was determined










































































































B Figure 6. Fetal T cell expansion and mem-
ory activation with PFA-fixed DCs
(A)Schematic representationof thesyngeneicT cell
expansionassay.DCs isolated from fetalmLNwere
primed with heat-killed fetal bacteria (for 8 h) fol-
lowedby1%PFA-inducedfixation.FixedDCswere
then presented to CTV-labeled T cells from the
same organ (mLN). At day 6, T cell expansion is
assayed by dye dilution using flow cytometry.
(B) Representative flow cytometry histograms for
T cell expansion (17-weeks EGA fetal mLN). CTV-
labeled T cells were incubated with bacteria (fetal
Staphylococci) primedDCs for 6 days. For controls,
T cells were incubated with unprimed DCs (no
bacteria) or CD3/28 Dynabeads as a negative and
positive control, respectively. T cell expansion is
assayed by measuring dye dilution using flow cy-
tometry. The conditions shown are T cells + DCs
alone (gray), T cells + fetal Staphylococci primed
DCs (blue), T cells + fetal Staphylococci primed
PFA-fixed DCs (orange), and T cells + CD3/28 Dy-
nabeads (magenta).
(C) Total T cell number (absolute count) as counted
by CountBright beads, post 6 day incubation,
plotted for all the conditions (n = 4). Statistical sig-
nificance between experimental groups was
determined by paired t test (****p < 0.0001, ***p <
0.001, **p < 0.01).
(D) Frequency of CTVneg-expandedmemory T cells
(CD45RO+, CTVneg) plotted for all conditions.
(E) Frequency of expanded CD69+ active memory
T cells (CTVneg) plotted for all conditions. Statistical
significance between experimental groups was
determined by two-tailed, unpaired Student’s t test
(****p < 0.0001, ***p < 0.001, **p < 0.01).
See also Figure S6.
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Articlepresentation. We fixed fetal DCs post bacterial priming with 1%
paraformaldehyde (PFA), prior to T cell presentation, to ensure
that the responses obtained reflected only the processing events
that occurred due to antigen exposure (Figure 6A). We selected
fetal isolated Staphylococci for this priming because it was spe-
cifically enriched in the fetal gut (Figures 2G and 2H) and showed
significant T cell activation in the previous assay (Figure 5). Inter-
estingly, we observed similar fetal T cell expansion profile with
both fixed and non-fixed DCs; however, the extent of prolifera-
tion was lower in fixed DCs asmeasured by absolute T cell count
post 6 days of exposure (Figures 6B and 6C). The number of
T cells surviving and proliferating with live DCs was higher than
fixed DCs, although both were significantly higher than the un-
primed DC control (Figure 6C). This observation suggests the ef-
fect of bacterial exposure on fetal T cell expansion is contributed
by both antigen presentation as well as cytokine-mediated sig-
nals. However, antigen presentation alone is sufficient to drive
the proliferation of a significant number of T cells in response
to bacterial signals. These expanded T cells were CD45RO+
and a significant proportion was CD69+, suggestive of an acti-
vated memory response toward fetal bacteria (Figures 6D and
6E, representative flow cytometry plots in Figures S6A–S6C).
To further validate these observations with an independent
method, we also used protein transport inhibitors (PTI) (combi-
nation of monensin and brefeldin A) to block cytokine production12 Cell 184, 1–16, June 24, 2021post bacterial priming of DCs (Figure S6D). This approach also
showed similar T cell expansion and activation response as in
the case of PFA-induced fixation (Figures S6E–S6H).
Taken together, these observations suggest that fetal mLN
T cells exhibit an activated memory response toward microbial
antigens encountered in utero. Further studies are required to
explore the antigenic specificities of these T cell-microbial inter-
actions in human fetal organs and the synergy with a non-antigen
specific (cytokine-mediated) response toward the extent of
proliferation.
DISCUSSION
The events occurring during fetal gestation are essential for the
overall development and growth of the individual. Key factors
transferred from the mother to the fetus during this process
establish the cornerstones of early life immunity and life-long
tolerance. Various studies have recently suggested that certain
antigens aswell as bacterial entitiesmay cross the placental bar-
rier andmake their way to fetal organs (Aagaard et al., 2014; Cao
et al., 2014; Li et al., 2019; McGovern et al., 2017; Mold et al.,
2008; Rackaityte et al., 2020; Schreurs et al., 2019; Stras et al.,
2019; Willyard, 2018). A recent report from our group also
demonstrated that human fetal mast cells are primed and sensi-
tized during gestation through maternal immunoglobulin E (IgE)
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Articlethat cross the placental barrier (Msallam et al., 2020). Interest-
ingly, a recent report on plant development showed partial inher-
itance of plant microbiome by vertical transmission through
seedling (Abdelfattah et al., 2021). All these observations open
a new avenue in developmental immune-priming wherein
maternal-derived microbial entities may condition the progeny
toward future antigenic exposures in life.
Our findings demonstrate that healthy human fetal tissues (in
the 2nd trimester of gestation) contain effector Tems, a sparse
biomass of bacteria, and an active memory T cell response to-
ward fetal bacteria. We also demonstrate direct spatial localiza-
tion of bacterial entities, localized within the lumen of developing
fetal gut, during the 2nd trimester of gestation. These data are in
line with recent studies that indicated antigenic priming of the
fetal immune system begins during gestation (Halkias et al.,
2019; Li et al., 2019; McGovern et al., 2017; Rackaityte and Hal-
kias, 2020; Rackaityte et al., 2020; Schreurs et al., 2019; Stras
et al., 2019). However, our study demonstrates for the first
time that such microbial presence primes the fetal immune sys-
tem, thereby putting early microbial memory in the context of
fetal immune priming, a concept not explored before in fetal im-
munity. It will be interesting to explore the precise nature of these
microbial antigen-specific circulatory and tissue-resident im-
mune cells in human fetal organs, and their potential role in im-
parting selective defense against pathogenic microbes in
neonatal and adult life. Taken together, these findings havewider
implications in understanding the key factors involved in fetal im-
mune system development and priming in utero, which may set
the basis for life-long health and immunity of the organism.
Although we have taken particular care to minimize the risk of
contaminations in this study, we cannot completely exclude po-
tential confounders due to environmental factors. In particular,
fetal skin and placenta samples will have been exposed to
vaginal microbiota during delivery or by the operator’s skin
(Chen et al., 2017; Ravel et al., 2011). However, the existence
of a spatially diverse microbial signal in fetal tissues, their ability
to culture-expand anaerobically, and the presence of microbial
antigen-specific memory T cell activation, are difficult to recon-
cile with either systematic biases or random noise. Collectively,
our data suggest a low but consistent presence of microbes in
at least some of the healthy human fetuses in the 2nd trimester
of gestation. Recent reports of the presence of microbes in fetal
lung and gut provide independent assertions to our findings (Al
Alam et al., 2020; Rackaityte et al., 2020). However, this is an
area of constant exploration and evidence from various spheres
of technological advances is needed to even partially under-
stand the dynamics of fetal development and immune priming.
Limitations of the study
This study providesmultiple evidence for the presence of livemi-
crobes in human fetal tissues, however, there are several
outstanding limitations to be addressed in future studies. First,
the precise source of bacteria in fetal tissues still remains un-
known. More clinical studies with access to pertinent maternal
samples are required to determine the source of origin and the
trajectory of bacterial entry to fetal organs. Second, although
we have undertaken a wide array of controls in this study,
contamination from maternal organs, especially from the lowergenital tract at delivery, cannot be formally ruled out. Sequencing
thematernal uterine microbiome, possibly at the time of delivery,
and the fetal microbes may address this issue. We acknowledge
that the species/genera specificities for fetal organs is limited in
this study, and more detailed metagenomics approaches will be
required to precisely determine the key bacterial species present
in fetal tissues and their niche preferences.
Last, the antigenic specificities of fetal T cell-microbial interac-
tions and its synergy with a non-specific antigen response (cyto-
kine-mediated) needs further exploration as we cannot formally
rule out the possible contribution of a super-antigen-based acti-
vation or a pan-bacterial response against fetal bacteria. Further
studies are required to address these possibilities in the future.
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Mold, J.E., Michaëlsson, J., Burt, T.D., Muench, M.O., Beckerman, K.P.,
Busch, M.P., Lee, T.-H., Nixon, D.F., and McCune, J.M. (2008). Maternal allo-
antigens promote the development of tolerogenic fetal regulatory T cells in
utero. Science 322, 1562–1565.
Mold, J.E., Venkatasubrahmanyam, S., Burt, T.D., Michaëlsson, J., Rivera,
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CD45RO (clone UCHL1) PE-Cy7 BD Biosciences Cat# 337168, RRID: AB_647426
CD69 (clone FN50) Biotin BioLegend Cat# 310924, RRID: AB_2074958
Streptavidin BUV737 BD Biosciences Cat# 612775, RRID: AB_2870104
DAPI Solution Thermo Fisher Scientific Cat# 62248
Antibodies (CyTOF)
CD3 (clone UCHT1) metal channel 139 BioLegend Cat# 300402, RRID: AB_314056
CD4 (clone SK3) metal channel 148 BioLegend Cat# 344625, RRID: AB_2563749
CD8 (clone SK1) metal channel 144 BioLegend Cat# 344727, RRID: AB_2563762
CD11b (clone ICRF44) metal channel 209 Fluidigm Cat# 3209003, RRID: AB_2687654
CD14 (clone M5E2) metal channel 112/114 BioLegend Cat# 301802, RRID: AB_314184
IL-4 (clone 8D4-8) metal channel 145 BioLegend Cat# 500707, RRID: AB_315119
GATA3 (clone TWAJ) metal channel 151 Thermo Fisher Scientific / eBioscience Cat# 14-9966-82, RRID: AB_1210519
IFN-g (clone B27) metal channel 168 BioLegend Cat# 506513, RRID: AB_315446
T-bet (clone 4B10) metal channel 163 Bio X Cell Cat# BE0100, RRID: AB_10950173
IL-17A (clone BL168) metal channel 169 BioLegend Cat# 512302, RRID: AB_961399
ROR gamma (t) (clone AFKJS-9) metal
channel 162
Thermo Fisher Scientific / eBioscience Cat# 14-6988-82, RRID: AB_1834475
CD45RA (clone HI100) metal channel 171 BioLegend Cat# 304102, RRID: AB_314406
CD45RO (clone UCHL1) metal channel 142 BioLegend Cat# 304202, RRID: AB_314418
CD69 (clone FN50) metal channel 167 BioLegend Cat# 310902, RRID: AB_314837
CD152 (clone BNI3) metal channel 155 BD Biosciences Cat# 555851, RRID: AB_396174
CD274/PD-L1 (clone 29E.2A3) metal
channel 156
BioLegend Cat# 329719, RRID: AB_2565429
HLA-DR (clone L243) metal channel 143 BioLegend Cat# 307612, RRID: AB_314690
LAG3 (clone 17B4) metal channel 170 Abcam Cat# ab40466, RRID: AB_776098
CD279/PD-1 (clone EH12.2H7) metal
channel 147
BioLegend Cat# 329941, RRID: AB_2563734
Ki-67 (clone 20Raj1) metal channel 166 Thermo Fisher Scientific / eBioscience Cat# 14-5699-82, RRID: AB_2016711
CD31 (clone WM59) metal channel 172 BioLegend Cat# 303102, RRID: AB_314328
TCR-gamma delta - FITC (clone 5A6.E9) Thermo Fisher Scientific Cat# TCR1061, RRID: AB_223500
Anti-FITC (clone FIT-22) metal channel 146 BioLegend Cat# 408302, RRID: AB_528901
TCR-ab-PE (clone T10B9.1A-31) BD Biosciences Cat# 555548, RRID: AB_395932
(Continued on next page)
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Anti-PE (clone PE001) metal channel 176 BioLegend Cat# 408102, RRID: AB_2168924
CD197/CCR7 (clone G043H7) metal
channel 154
BioLegend Cat# 353202, RRID: AB_10945157
CXCR5 (clone RF8B2) metal channel 159 BD Biosciences Cat# 552032, RRID: AB_394324
CD25 (clone M-A251) metal channel 150 BD Biosciences Cat# 555429, RRID: AB_395823
CD127 (clone A019D5) metal channel 149 BioLegend Cat# 351302, RRID: AB_10718513
FOXP3 (clone PCH101) metal channel 165 Thermo Fisher Scientific / eBioscience Cat# 14-4776-82, RRID: AB_467554
CD304 (clone 3E12) metal channel 157 BioLegend Cat# 145202, RRID: AB_2561841
Helios (clone 22F6) metal channel 174 BioLegend Cat# 137202, RRID: AB_10900638
TGF-b1 (LAP) (clone TW4-2F8) metal
channel 153
BioLegend Cat# 349602, RRID: AB_10645476
IL-10 (clone JES3-9D7) metal channel 158 BioLegend Cat# 501402, RRID: AB_315168
TNFa (clone MAb11) metal channel 152 BioLegend Cat# 502902, RRID: AB_315254
Granzyme B (clone CLB-GB11) metal
channel 173
Abcam Cat# ab103159, RRID: AB_10715242
IL-2 (clone MQ1-17H12) metal channel 164 BioLegend Cat# 500302, RRID: AB_315089
IL-15 (clone BH1509) metal channel 160 BioLegend Cat# 515002, RRID: AB_2561319
GM-CSF (clone BVD2-21C11) metal
channel 161
BioLegend Cat# 502302, RRID: AB_315216
CD45-A (clone HI30) metal channel 89 Fluidigm Cat# 3089003, RRID: AB_2661851
CD45-B, C or D (clone HI30) metal channel
115, 141, 175
BioLegend Cat# 304002, RRID: AB_314390
Cell-ID Intercalator-Ir metal channel
191/193
Fluidigm Cat# 201192B
Cisplatin (Live/Dead) metal channel 195 Sigma-Aldrich Cat# 15663-27-1
Biological samples
Adult blood samples National University Hospital (NUH) N/A
Human adult Gut and Lung samples National University Hospital (NUH) N/A
Human fetal samples, fetal blood, and
cord blood
Division of Obstetrics and Gynaecology, KK




blocks of fetal tissues
The Advanced Molecular Pathology
Laboratory (AMPL) of Institute of Molecular
and Cell Biology (IMCB)
N/A
H&E staining and paraffin unstained slides The Advanced Molecular Pathology
Laboratory (AMPL) of Institute of Molecular
and Cell Biology (IMCB)
N/A
Critical commercial assays
HyClone RPMI 1640 Media Cytiva (Formerly GE Healthcare Life
Sciences)
Cat# SH3025501
Iscove’s Modified Dulbecco’s Medium (1x) Thermo Fisher Scientific Cat# 12440053
Human Serum Sigma-Aldrich Cat# H4522
CellTrace Violet Cell Proliferation Kit Thermo Fisher Scientific Cat# C34557
Human IL-2 IS premium grade Miltenyi Biotec Cat# 130-097-745
Human Flt3-Ligand premium grade Miltenyi Biotec Cat# 130-096-479
Dynabeads Human T-Activator CD3/CD28 Thermo Fisher Scientific Cat# 11131D
Sodium Pyruvate (100mM) GIBCO Cat# 11360-070
Penicillin-Streptomycin GIBCO Cat# 15140122
LB Broth Miller, Bacterial Culture Media 1st BASE Cat# BIO-4000-1kg
Cyclopore Polycarbonate Membrane Whatman Cat# 7060-2501
Stainless Steel Insect Pin Roboz Cat# RS-6082-25
(Continued on next page)
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Osmium Tetroxide, 1 g crystal Ted Pella, Inc. Cat# 18456
Glutaraldehyde, 25% EM grade, 100ml Ted Pella, Inc. Cat# 18427
RNAscope Multiplex Fluorescent Reagent
Kit v2 Assay
ACDBio Cat# 323100
RNAscope Probe Diluent ACDBio Cat# 300041
Opal 7-Color kit Perkin Elmer Cat# NEL821001KT
Xylenes Sigma Cat# 534056
RNAscope Probe- EB-16S-rRNA ACDBio Cat# 464461
RNAscope Probe - Hs-EPCAM ACDBio Cat# 310281-C3
ProLong Diamond AntifadeMountant Thermo Fisher Scientific Cat# P36970
Deposited data
Raw data files for 16S rRNA sequencing NCBI Gene Expression Omnibus GEO: GSE169306
Software and algorithms
inForm Tissue Analysis Software Akoya Biosciences https://www.akoyabio.com/phenoptics/
software/inform-tissue-finder/
Phenochart Whole Slide Viewer Akoya Biosciences https://www.akoyabio.com/support/
software/
ImageJ National Institutes of Health and the
Laboratory for Optical and Computational
Instrumentation
https://imagej.nih.gov/ij/
Cell Profiler Broad’s Institute of Imaging Platform https://cellprofiler.org/
Diva BD Biosciences https://www.bdbiosciences.com/en-us
FlowJo v.10.5.3 Tree Star Inc. https://www.flowjo.com
GraphPad Prism version 7 and 9 Graphpad https://www.graphpad.com/
scientific-software/prism/
R 4.4 The R Foundation https://www.r-project.org
UMAP (McInnes et al., 2018) https://github.com/lmcinnes/umap
SMuRF 1.0 CRAN https://cran.r-project.org/web/packages/
smurf/index.html
QIIME 1.8.0 QIIME http://qiime.org/
emperor 1.0 Biocore https://biocore.github.io/emperor/
vegan v2.5.7 CRAN https://cran.r-project.org/web/packages/
vegan/index.html
Python 2.7.0 Python Software Foundation https://www.python.org/
Python 3.7.0 Python Software Foundation https://www.python.org/
matplotlib 3.2.1 PyPI https://pypi.org/
numpy 1.19.4 PyPI https://pypi.org/
pandas 0.25.3 PyPI https://pypi.org/
seaborn 0.9.0 PyPI https://pypi.org/
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Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact:
Florent Ginhoux (florent_ginhoux@immunol.a-star.edu.sg)
Materials availability
This study did not generate new unique reagents.
Data and code availability
All the raw sequencing data reported in this paper is available on GEO and the accession number is GSE169306 (Human fetal im-
munity and microbial priming during early development). The authors declare that all data supporting the findings of this study are
available within the manuscript and/or its Supplementary Files or available on request.Cell 184, 1–16.e1–e8, June 24, 2021 e3
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ArticleEXPERIMENTAL MODEL AND SUBJECT DETAILS
Human samples
Human fetal and adult tissues, cord blood, adult blood and amniotic fluid, were obtained in accordance from Singapore SingHealth
andNational Health Care Group Research Ethics Committees. All women gavewritten consent to the use of fetal tissues according to
internationally recognized guidelines (Polkinghorne, 1989). Review of the guidance on the research use of fetuses and fetal material.
CM 762). All fetal tissues (placenta, lung, thymus, spleen, gut, mesenteric lymph nodes, and skin) were obtained from 2nd trimester
(12-22 weeks EGA) elective pregnancy terminations carried out for socio-psychological reasons. All fetuses were considered struc-
turally normal on ultrasound examination prior to termination and by gross morphological examination following termination. Fetal
tissues from 2nd trimester of gestation were used for this study (Table S1). The study of fetal blood was approved by the Hôpital
Erasme ethics committee (ULB). All participants (or mothers, in the case of fetal samples) gave written informed consent. We ob-
tained fetal blood (between 23 and 37 weeks EGA) as described previously (Dimova et al., 2015).
Fetal dissection and organ collection
Mid-trimester terminations were medically induced by the use of prostaglandins, and the fetus was delivered through the birth canal.
Fetal organs were collected under sterile conditions in a tissue culture hood. Aseptic equipment was used for collecting fetal tissues.
Fetal skin was collected first. Due to the risk of contamination from vaginal microbes, great care was taken to minimize the risk of
contamination of internal organs. Fetal skin across the abdomenwas cut and pinned back to prevent it from touching internal organs.
Fresh aseptic instruments were then used to remove internal organs. Fetal lungs were then removed, followed by the thymus, spleen,
liver and gastrointestinal tract. The mesenteric lymph nodes were removed with the gastrointestinal tract. If a placenta was obtained,
it was processed last. Tissues were processed as described below for suspension mass cytometry assays and microbiome studies.
When tissues were used for both arms of the study, samples were divided using aseptic equipment. Sterile equipment was rinsed in
PBS and this PBS was used as an environmental control, along with unused PBS and environment air swabs.
Fetal organ dissection in detail:
Prior to start of the harvest procedure, the entire bio-safety cabinet was thoroughly disinfected.
Order of Harvest- Skin, Liver, Gut, Spleen, Thymus, Lungs and Placenta
Separate (new and sterilized) dissection tools were used for dissection of each organ to avoid instrument associated contamina-
tions as well as cross-tissue contaminations.
Skin: Starting the dissection of skin, using a scissor, an incision was made into the skin (back, chest and abdomen) and carefully
separated the skin from the muscle, followed by isolation and transfer to buffer/media.
Liver: Abdominal cavity was entered, and the liver carefully detached from the diaphragm and the anterior abdominal wall, and
placed in sterile buffer/media.
Intestines: The omentum andmesenteric was dissected, and intestines snipped near the rectumand at the gastric-duodenal junc-
tion, rinsed with PBS transferred to sterile buffer/media.
Spleen: The spleen was dissected from its splenic portal attachments, placed in sterile buffer/media.
Thymus: A cut is made along the sternum to the neck to access the thoracic cavity. The thymus can be identified as fatty tissue
attached to the upper mediastinum, where it is isolated with a pair of sterile forceps, and placed in sterile buffer/media.
Lungs: Using the pointed/fine-tip forceps, a pinch on the bronchus was exerted and a scalpel was used to remove the lung from
the thoracic cavity and transferred to a sterile buffer/media.
Placenta: one cm3 of placental tissues was obtained near the cord insertion and transferred to sterile buffer/media. This biopsy
includes both fetal and decidual surfaces of the placenta.Cell isolation for suspension mass cytometry assays
Fetal organs were mechanically dispersed and incubated with 0.2 mg/ml collagenase (TypeIV; Sigma Aldrich) and DNase I (20,000U/
ml, Roche) in RPMI with 10% FCS for 1 hour in a 6 well plate. Viability was typically 80%–90%measured by DAPI exclusion (Partec).
Fetal gut was initially cut longitudinally through the center, washed extensively in PBS until all inner content (meconium) was removed
and the PBS was clear, before mechanical dispersion and digestion as above, for 1h. Adult lung specimens were obtained from peri-
tumoral tissue. Adult lung specimens were prepared as described previously (Aiuti et al., 2013; Mattar et al., 2012). T cells were
enriched isolated to 90% purity from adult and fetal organs by negative selection using T cell enrichment kits (Miltenyi Biotec) and
separated on an AutoMacs following manufacturer’s instructions.
Suspension mass cytometry staining, barcoding, acquisition and data pre-processing
T cells were stained as previously described and then analyzed by CyTOF. Briefly, T cells were stimulated with phorbol 12-myristate
13-acetate (PMA) (150 ng/ml, Sigma-Aldrich) and ionomycin (750 ng/ml, Sigma-Aldrich) for 5h, blockedwith secretory inhibitors, bre-
feldin A (1:1000, eBioscience) and monesin (1:1000, Biolegend) after one hour, for the last 4 hours, in 10% v/v human serum, 1% v/v
PSG, RPMI at 37C, 5% CO2. The cells were then washed and stained with cell viability dye cisplatin (200 mM, Sigma-Aldrich) fore4 Cell 184, 1–16.e1–e8, June 24, 2021
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Article5 min at room temperature. The cells were re-washed and each individual sample was barcoded with a unique combination of anti-
CD45 conjugated with either heavy metal 89, 115, 141 or 175, as previously described for 25 min on ice (Lai et al., 2015; McGovern
et al., 2017). The barcoded cells were washed and stained with a surface antibody cocktail in 4% v/v heat-inactivated FBS, 2mM
EDTA, 0.05% w/v sodium azide in pH 7.4 PBS for 30 min on ice. The cells were again washed and re-suspended in fixation/perme-
abilization buffer (1:3, eBioscience) for 45 min on ice. The permeabilized cells were then stained with an intra-antibody cocktail (1:10,
permeabilisation buffer, eBioscience) for 45 min on ice, before washing and staining with a DNA intercalator Ir-191/193 (1:2000 in
1.6% w/v paraformaldehye, Fluidigm) overnight at 4C or for 20 min on ice. Finally, the cells were washed and re-suspended with
EQTM Four Element Calibration beads (1:10, Fluidigm) in ultra-pure distilled water at 1x106 cells/ml. The cell mixture was then loaded
and acquired on a Helios mass cytometer (Fluidigm) calibrated with CyTOF Tunning solution (Fluidigm). The output FCS files were
randomized and normalized with the EQTM Four Element Calibration beads against the entire run, as per the manufacturer’s recom-
mendations. Key Resources Table contains all the antibodies with specifications used in CyTOF experiments.
UMAP Analysis
The automated analysis was performed by the UMAP algorithm as described previously (Becht et al., 2018). FlowJo software and R
package were used for data analysis.
DNA extraction
DNA from fetal tissues was extracted according to the protocol as previously described (Rancati et al., 2008), except that the volume
of Breaking Buffer and phenol/chloroform/IAA used was 400 mL. Fetal microbiome reagent and environmental controls were concur-
rently performed during the DNA extraction process (Table S2 contains all the primers used, if not alreadymentioned in themethods).
BactQuant qPCR
The qPCR was performed according to the protocol as previously described (Liu et al., 2012), with slight modifications. Briefly, the
PCR reactions were run in 10uL reactions and were composed of the universal 16S BactQuant primers (50-CCTA
CGGGDGGCWGCA-30 and 50-GGACTACHVGGGTMTCTAATC-30) at 1.8uM, probe (6FAM-50-CAGCAGCCGCGGTA-30-MGBNFQ)
at 225 nM, TaqMan Universal PCR MasterMix x2, water and undiluted sample DNA (3uL). The amplification was performed on a
7900HT Real Time PCR System (Applied Biosystems) with cycling conditions of 50C for 3 min, 95C for 2 min, and 40 cycles of
95C for 15 s and 60C for 1min. Cycle threshold value (Ct value) for each 16 S qPCR reaction were obtained using a manual Ct
threshold of 0.02 andmanual baseline between cycles 1-15 in the Sequence Detection Systems v2.4 software (Applied Biosystems).
The qPCR for each sample was run as technical duplicates or more depending on sample availability, and the values were averaged
to give the final Ct value used in data analysis.
High-throughput 16S rRNA gene sequencing at SIgN (Singapore Immunology Network)
Genomic DNA isolated from fetal tissues and control samples were treated with McrBC restriction enzyme (New England BioLabs)
according to manufacturer’s instructions, to remove host DNA and to enrich for microbial DNA. The treated DNA samples were pu-
rified using 0.8X ratio of AMPure XP beads (Beckman Coulter). The McrBC-treated, purified gDNA was quantified using Quant-iT TM
Picogreen dsDNA Assay kit (Invitrogen). For amplification of the 16S rRNA gene-variable regions three rounds of amplification were
performed using 100ng of McrBC-treated gDNA with LongAmp Taq DNA polymerase (New England Biolabs) according to manufac-
turer’s instructions. The first step aimed at enriching microbial sequences was performed using primers that amplify V2-V6 regions
(Table S2). PCR cycling parameters consisted of initial denaturation step for 30 s at 94C, followed by 12 cycles of 15 s at 94C, 30 s at
45C, and 1min at 65Cwith a final extension for 10min at 65C. Subsequently a nested PCRwas performed targeting V4-V5 regions
using the enriched V2-V6 amplicon as template. PCR Cycling parameters for amplifying V4-V5 regions were similar to V2-V6 PCR
cycling profile, except that the extension was for 30 s at 65C. The final amplification step involved addition of barcodes for identi-
fying, de-multiplexing individual samples and Illumina adaptor sequences to the V4-V5 enriched product using communal primers.
Communal PCR amplification consisted of initial denaturation step for 30 s at 94C, followed by 30 cycles of 15 s at 94C, 30 s at
45C, and 1 min at 65C with a final extension for 10 min at 65C. Equimolar concentrations of the prepared libraries were pooled
and electrophoresed using 1% agarose gel. Pooled amplicon libraries were gel-purified using the Qiaquick Gel Extraction Kit
(QIAGEN). Integrity of gel-purified libraries were validated using the High Sensitivity DNA kit (Agilent Technologies). The libraries
were quantified using KAPA Library Quantification Kit (Kapa Biosystems) to ascertain the loading concentration and sequenced
on a HiSeq 2500 System (Illumina) operated in Rapid Run Mode to generate 2 3 250 bp paired-end reads.
High-throughput 16S rRNA gene sequencing at WIS (Weizmann Institute of Science)
DNA Extraction
Samples from Fetus ID W1 to W10 (10 fetuses- Table S1) were processed at WIS. DNA from fetal tissues was isolated according to
the protocol as previously described, designed to extract bacterial DNA (Geller et al., 2017; Nejman et al., 2020). Frozen tissues were
extracted with the UltraClean Tissue & Cells DNA Isolation kit (MoBio - #12334) according to the manufacturer’s instructions. A
30minute proteinase K (15 ml) digestion was done, and bead-beating was performed before (10 minutes) and after (5 minutes) diges-
tion. A heating step at 90 C for 45 min was added after proteinase K digestion and then cooled at room temperature for 10 minutes.Cell 184, 1–16.e1–e8, June 24, 2021 e5
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was added (100%, 200 ml) to the tubes followed by a short vortex mix and the whole mixture (together with beads) was loaded onto
the columns in two steps. Wash and elution steps were done according to manufacturer’s instructions. Pre-heated (70C) elution
buffer (100ul) was added to the columns. Columns were incubated at 70C for 4min before DNA was eluted. All negative controls
were processed according to the exact same protocols.
16S amplification and deep sequencing
Five regions of the 16S rRNA gene were amplified using 100ng DNA as an input and a set of 10 multiplexed primers (0.2 mM each
primer), 0.2mMdNTPs (Larova GmbH) and 0.02U/ul of Phusion Hot Start II DNA Polymerase (Thermo Scientific #F549). Amplification
was done with an initial heating step of 98 C for 2min, 30 cycles of 10 s at 98 C, 15 s at 62 C, 35 s at 72 C followed by a final elongation















and one 8 nucleotide barcode-specific reverse primer (0.4 mM, RR5- CAAGCAGAAGACGGCATACGAGAT-NNNNNNNN-
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCT).
The amplicon was diluted into the reaction (10-fold) and amplifiedwith 6 cycles of 10 s at 98C, 15 s at 64C, 25 s at 72C’. Amplicons
were then combined into sub-libraries (40-50 amplicons) and each library was purified using Qiaquick PCR purification kit (QIAGEN
#28104) according to the manufacturer’s instructions. Multiple sub-libraries were then combined into the final library (100-430 am-
plicons) and further purified from primer dimers using Agencourt AMPure XP (Beckman Coulter #A63881) at a volume ratio of 1:0.85
(library: beads). The library (7pM) was supplemented with 15% PhiX (8pM) and sequenced on NextSeq 500 mid output (paired end
2x150) sequencers.
Microbiome data analysis
Sequencing data was pre-processed and mapped to the reference database as described (Cottier et al., 2018). Operational taxo-
nomic units (OTUs) occurring only once (singletons) were removed from the entire dataset. Samples with fewer than 500 reads
were removed. Alpha- (Shannon and Chao1 indices) and beta-diversity analyses (Bray-Curtis and weighted UniFrac distances)
were performed in QIIME (Caporaso et al., 2010) (v1.8.0) on OTU tables that had been rarefied to 1,000 reads per sample for
10 times (Table S3). Principal Coordinate Analysis (PCoA) plots were visualized with Emperor (Vázquez-Baeza et al., 2013). The
three-dimensional coordinates of the PCoA clusters from emperor results were then extracted to be plotted by python matplotlib
module (v3.3.3). Only fetal and PBS derived samples were selected for the graph. Permutational Multivariate Analysis of Variance
(PERMANOVA) test was done using the adonis function of vegan (v2.5.7) package in R. Table S3 contains all the samples and OTU
information.
Data Analysis in Weizmann Institute (WIS)
Reads were demultiplexed per sample and filtered if either a) Phred score was less than 30 in more than 25% of nucleotides or b)
more than three nucleotides had a Phred score of less than 10, or c) a read contained one or more ambiguous base calls. Unique
reads with low counts were discarded, and reads were matched to each of the five amplified regions based on the primers’ se-
quences. The SMURF package was applied to combine read counts from the five regions into a coherent profiling result solving a
maximum likelihood problem (Fuks et al., 2018). The Greengenes database (May 2013 version) was used as reference. To allow add-
ing WIS results to SIgN analysis pipeline, OTU picking requiring a minimum similarity of 99% was performed over SMURF’s results.
Table S4 contains all the OTU information for samples processed and sequenced at WIS.e6 Cell 184, 1–16.e1–e8, June 24, 2021
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To explore differentially enriched bacterial taxa (OTUs at the genus level) in fetal gut as compared to PBS and Spleen or Thymus (Fig-
ures 2H and S2K), normalized read counts information of the OTUs were retrieved from Table S3. Log2 Fold Change (LOG2FC) of the
OTUs were calculated in R (v. 4.0.3) statistical programs. The quadrant plots were made using the plot function. Each data points on
the plot were sized according to the relative percentage abundance of the OTUs in Gut as compared to PBS and spleen or PBS and
thymus. LOG2FCR 2was considered as the cut-off for OTUswhichwere differentially enriched inGut whereas a Relative Percentage
Abundance (RPA) of 3% is used as filtering criteria.
LOG2FC was calculate using the following formula.




Where Ai is the normalized read count for of the i
th OTU in Gut and Bi is the read count for the corresponding i
th OTU in PBS/thymus.
RPA for each OTU in gut is given by
RPAOTU = ðSGut 3 100ÞSGut +SðSpleenjThymusÞ +SPBSSGut = Counts of samples where reads exist for GutSðSpleenjThymusÞ = Counts of samples where reads exist for Thymus or Spleen
SPBS = Counts of samples where reads exist for PBS
Bacterial Isolation and Identification
Fresh fetal tissue biopsies were taken aseptically and inoculated into pre-reduced anaerobic basal broth supplemented with 5% de-
fibrillated horse blood, incubated anaerobically at 37C for 48h, and then plated on anaerobic basal agar supplemented with 5%
horse blood under aerobic or anaerobic conditions. Single bacterial isolates were streak-purified and then identified via standard
16S PCR and Sanger sequencing as follows. Briefly, single colonies were resuspended in 50 mL of Tris-EDTA; 1 mL of the suspension
was then subjected to 1 min denaturation at 98C, followed by 30 cycles of PCR (10 s at 98C, 30 s at 56C, 30 s at 72C) and a final
extension of 10 min at 72C, using Q5 High-Fidelity DNA polymerase (NEB) and V4-V5 primers listed in Table S2. PCR products
were then sequenced using V4-F as the primer, yielding sequencesR 330 nucleotides in length. Sequence ends were then trimmed
using DNALaser Gene Seqman Pro 15 (Quality stringency: high), followed by manual inspection and further trimming to exclude re-
gions with overlapping peaks. Chromatograms not yielding unique sequences were discarded and not processed further. Trimmed
sequences were then searched against the NCBI 16S ribosomal RNA sequences (Bacteria and Archaea) database using Megablast
(optimized for highly similar sequences) using default parameters. Species names of all top-scoring hits were reported (Table S5).
Sequence identity was generally R 97% for most of the species identified. Table S6 shows number of tissues positive for the given
bacteria, and number of colonies isolated for the given bacteria, across 8 fetal donors.
Identification of Fetal/PBS enriched Bacterial taxa
We aligned all 1194 sampled bacterial taxa (genus level, based on the OTU information in Table S3) as identified by high-throughput
16S rRNA sequencing, according to their abundance in PBS controls. We selected top bacterial genera that were specifically present
in any of the fetal tissues and top ones that were specifically enriched in PBS controls. A curated pandas Python library version
v0.25.3 was used to extract and align the OTU reads. The bacterial taxa which showed zero signal intensity across all sample types
were removed. For each sample type and bacterial identity, the mean signal intensity was calculated and plotted using thematplotlib
(v.3.2.1) and seaborn (v.0.9.0) Python libraries. Bacterial genera where signal intensity in PBS was higher or equal to those in fetal
samples were depicted as potential contaminants (PBS enriched taxa). Table S3 shows the OTU information for each sample. For
Figure S3D, we extracted the 16S rRNA gene sequencing data for 7 fetal donors (out of 8) which were simultaneously processed
for live culture-based sequencing as well. We then extracted the signal intensities for those bacterial taxa which were identified
by culture-based sequencing as shown in Figure 3D. Mean signal intensities were plotted according to their abundance in fetal tis-
sues, along with those in PBS controls (Table S3 contains the sample and OTU information for the given 7 fetal donors used in
Figure S3D).
Scanning Electron Microscopy imaging
Fetal gut samples (14 weeks EGA) were processed for Scanning Electron Microscopy imaging under sterile conditions. Briefly, the
region around mid-gut was selected for scanning and were cut open longitudinally to expose the luminal parts by using a binocular
dissecting microscope and pinned down to a silicone mat in four corners. The samples (in vitro bacterial samples and fetal gut sam-
ples) were immediately fixed in 2.5%glutaraldehyde overnight at 4C. Phosphate buffer solution (1X PBS) was used towash the over-
night fixed samples (2 changes, 20 minutes each) and the samples were kept in PBS. For bacterial cultures, bacteria isolated from
18 weeks EGA fetal lungs and gut (OD600 = 0.1) were co-incubated with nitrocellulose membrane in Luria-Bertani broth overnight at
37C to allow bacteria to attach the membranes, prior to fixation. The samples were post-fixed in 1% osmium tetroxide andCell 184, 1–16.e1–e8, June 24, 2021 e7
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Articledehydrated by using ascending concentrations of ethanol. After which, the samples were critical-point-dried, stuck on carbon stubs
and coated with 25 nm of gold. The samples were imaged on a Field Emission Electron Microscope (EM) at a voltage of 20 kV at
Electron Microscopy Unit at the National University of Singapore.
RNA in situ hybridization
Formalin-fixed paraffin-embedded (FFPE) slides were prepared from FFPE fetal tissue blocks. The tissue samples with a thickness of
2 microns were mounted onto glass slides and stored at room temperature. Slides were stained using the RNAscope Multiplex
Fluorescent Reagent Kit v2 Assay Kit (Advanced Cell Diagnostics) following manufacturer’s protocol. The slides were baked in a
dry oven for 1 hour at 60C. Following steps included deparaffinizing the slides using fresh xylene (2 washes for 5 minutes each)
and 100% ethanol (2 washes for 2 minutes each). The slides were then treated with RNAscope Hydrogen Peroxide for 10 minutes
at room temperature. Meanwhile, 200 mL of RNAscope 1X Target Retrieval Reagent was poured in a slide holder and kept in a
beaker filled with water on a hot plate to boil. The slides were washed and put in the slide holder for 15 minutes at 99C for target
retrieval. A hydrophobic barrier was drawn around the tissue using ImmEdge hydrophobic barrier pen. Few drops of RNAscope
Protease Plus was added onto the tissues and incubated for 30 minutes at 40C. RNAscope probes from ACDbio was used in
this experiment; EB-16 s-rRNA (Cat# 464461) in C1 channel and EPCAM (Cat# 310281) in C3 channel. The probe mix was added
onto the slide and probe hybridization was performed for 2 hours at 40C. The slides were then stored in 5X SSC overnight and ampli-
fication steps were performed the following day.
Opal 520 and Opal 690 dyes (Perkin Elmer, Cat# NEL821001KT) were selected for EB-16 s-rRNA and EPCAM probes respectively.
TheOpal dye dilution optimizedwas 1:500 for all samples except 1:250 dilution for liver samples (EPCAMprobe only). The slideswere
mounted using a drop of ProLong Diamond Antifade Mountant (Thermofisher, Cat#: P36970). The slides were imaged by Vectra
Polaris Automated Quantitative Pathology Imaging System. The images were edited using inForm image analysis software and co-
lor intensity for EB-16 s-rRNA was set to 150% (green) while EPCAMwas set to 120% (white). The whole slide scans of Hematoxylin
and eosin stained slides were imaged using Phenochart image analysis software.
For image quantification, Imagej and Cell Profiler softwares were used. Using Imagej software, the images were split into single
channel greyscale images. These greyscale images were added into Cell Profiler software and analyzed using a published pipeline
(Erben et al., 2018). The threshold correction factor in the pipeline was in the range of 1-4 for EB-16 s-rRNA and 1.7-2.5 for EPCAM.
In vitro syngeneic T cell expansion assay
DC and T cells from fetal Mesenteric Lymph Node (mLN) were isolated by fluorescence activated cell sorting (FACS) using BD
FACSAria IV (BD Biosciences). T cells were isolated by negative selection, gating for lineage negative (lineage- CD19/20/56) and
HLA-DR negative cells, with upto 80 percent purity. HLA-DR+ and CD14- cells were selected for DC isolation. Fetal bacteria (Lac-
tobacilli and Salmonella) were isolated and cultured as indicated above, in 5% defibrillated horse blood at 37C for 48h. Culture
stocks were made and snap frozen at 80C. At the day of experiment, frozen vials were thawed and bacteria were washed with
sterile PBS followed by heat inactivation at 65C for 20 minutes, with intermittent vortex mixing. Flow sorted DC were plated in a
96 well plate at the density of 1000 cells per well in the DC specific media: IMDM, 10% human serum AB, 1% v/v sodium pyruvate,
2mM glutamine, and 200ng/ml human FLT3 ligand (cat no. 130-096-479, Milteny Biotec). Fetal bacteria (heat-killed) were added to
DC with an MOI of 1:10 (10,000 bacteria per 1000 DC) and incubated for 8 hours at 37C. T cells were labeled with CellTrace Violet
(CTV) dye and a small portion was analyzed by flow cytometry for dye incorporation and cell viability. DC were gently washed with
sterile PBS and CTV labeled T cells were added to each well in 1:10 ratio of DC:T cells (10,000 T cells per 1000 DC), and incubated for
6 days in T cell media: IMDM, 10% human serum AB, 1% v/v sodium pyruvate, 2mM glutamine, 1% Pen-Step solution (antibiotic)
(Hegazy et al., 2017). Post 6 days culture, T cells were harvested and stained with fluorescent antibodies followed by flow-cytometry
analysis using BD-LSR-V (BD biosciences) and data were analyzed using FlowJo software.
For PFA inducedDC fixation: DCwere first infectedwith fetal bacteria for 8 hours, followed by fixation using 1%PFA for 10minutes.
The PFA was then removed after 10 mins and the reaction was quenched with 200mM glycine. Cells were washed twice with sterile
PBS and RPMI respectively. Rest of the process of T cell addition and incubation proceeds as explained earlier.
For PTI induced blocking of cytokine release: Post bacterial priming of DC for 8 hours, cells were incubated with a combination of
Brefeldin A and Monensin (Protein Transport Inhibitors) for 2 hours. The cells were then washed twice with sterile PBS and RPMI
respectively. Rest of the process of T cell addition and incubation proceeds as explained earlier.
Statistical analysis
Statistical analysis was performed in GraphPad Prism 7 using the specific tests indicated in the respective figure legends. The num-
ber of samples used for each analysis (n) is indicated in the respective figure or legend.e8 Cell 184, 1–16.e1–e8, June 24, 2021
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Figure S1. Study design and T cell diversity during the 2nd trimester of human fetal development, related to Figure 1
(A) Schematic for introducing the study design and techniques used. Precisely, fetal tissues were harvested from the human fetuses under sterile conditions and
were subjected to mass cytometry (CyTOF) for T cell identification, 16S rRNA gene sequencing for bacterial detection, anaerobic culture based bacterial
propagation and in-vitro T cell expansion assay.
(B) Flow cytometry plots and gating strategy for fetal and adult Tregs and PD1+ Ki67+ Tregs. CD25+ FOXP3+ Tregs were further checked for CD152 expression
and more than 80% of Tregs were found to be CD152+ as well.
(C) Representative flow cytometry plots for fetal and adult Tregs
(D) Percentage of PD1+ Ki67+ Tregs in fetal versus adult tissues and in blood samples (fetal, adult and cord blood) as determined by mass cytometry analysis
(input gating strategy and reference plots in Figure S1B).
(E) Representative flow cytometry plots for cytotoxic T lymphocytes (CTL: CD8+ Tbet+ Granzyme B+ T cells) in fetal and adult samples. CTL’s are gated on total
CD8+ T cells.
(F) Percentage of cytotoxic T cells (CD8+ CTL) in fetal versus adult tissues and in blood samples (fetal, adult and cord blood) as determined by mass cytometry
analysis.
(G) Input gating strategy and representative flow-cytometry plots for identification of TNF+ and IFNg+ cells in CD4+ and CD8+ T cells
(H) Percentage of IFNg+ cells in CD4+ (left) and CD8+ (right) T cells in fetal and adult tissues and in blood samples (fetal, adult and cord blood) as determined by
mass cytometry analysis.
(I) Input gating strategy and representative flow-cytometry plots for identification of CD4+/CD8+ CD45RO+ memory and effector memory T cells (Tem). For
effector memory T cell phenotype identification, CD45RO+ memory T cells were gated and assessed analyzed for TNF and IFNg expression as shown.
(J) Percentage of IFNg+ effector memory T cells (Tem) in CD4+ (left) and CD8+ (right) memory T cells in fetal and adult tissues and in blood samples (fetal, adult and
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Figure S2. Contamination controls and high-throughput 16S rRNA gene sequencing of fetal tissues, related to Figure 2
(A) Schematic to show the contamination controls taken at each step ranging from fetal dissection to tissue processing, bacterial culturing, DNA extraction, and
sequencing. The controls taken at each step can be divided into four major categories. Operator control includes the hand swabs of the operators handling the
fetal tissues while dissection and processing and while DNA extraction. Environment control denotes control swabs taken from work surfaces like PCR hood,
laminar flow, work bench etc. PBS buffer control denotes PBS used at each step of tissue processing and DNA extraction. Reagent control encompasses the
molecular reagents used for DNA extraction thereby depicting the contaminations present in extraction kits and associated reagents.
(B) Workflow employed for fetal tissue processing, dissection, DNA extraction and sequencing. Contamination controls taken at each step are denoted by swab-
handles and color coded according to panel A (left).
(C) Principal Coordinate (PC) analysis based on Weighted UniFrac distance to the PBS. PC analysis is this plot is shown in terms of early versus late estimated
gestational age (ega). 2nd trimester fetal samples were divided in two groups, early (< 16 weeks) and late (R16 weeks) EGA, and color coded accordingly. The
percentage of variance explained by the PC’s is indicated next to each axis.Weighted UniFrac distance of fetal tissues to their matched PBS controls, segregated
by early (< 16 weeks) and late (R16 weeks) EGA. Unpaired Mann-Whitney test: ***p < 0.0005.
(D) Similar analysis as in panel (B), further broken down into tissue types. Weighted UniFrac distances between all available PBS samples is also displayed as a
reference (within PBS bar). Unpaired Mann-Whitney test: *p < 0.05; ***p < 0.0005
(E) CT values for fetal organs plotted to determine the extent of bacterial DNA present in each sample. Lower CT value for a sample represents higher content of
DNA being amplified. Here the CT values for each organ plotted and compared with those of those in fetal thymus. As shown, most of the fetal tissues had
significantly higher microbial DNA content than fetal thymus.
(F) Shannon index boxplot of samples, including reagent, environmental and PBS controls, and fetal tissues. The gray shade represents the cutoff value which is
95th percentile of all PBS samples (~6.324) and is used to perform the Fisher’s exact test in main Figure 2D.
(G) Analysis similar to the panel E, except for Chao1 index used as the a-diversity metric.
(H) Analysis similar to Figure 2E, except for Bray-Curtis distance used as the b-diversity metric (instead of Weighted UniFrac distance)
(I) Unnormalized Weighted UniFrac distances of fetal tissues against their matched PBS controls. Analysis was restricted to fetuses with data available for R 2
tissues. Paired Mann-Whitney test: *p < 0.05; **p < 0.005, ***p < 0.0005. This analysis is similar to that in Figure 2F, except that ‘unnormalized’ Weighted UniFrac
distances were used for b-diversity metric.
(J) Bray Curtis distances of fetal tissues against their matched PBS controls. Analysis was restricted to fetuses with data available forR 2 tissues. Distances were
normalized within fetus, by dividing each value by the average Bray-Curtis distance within each fetus. Paired Mann-Whitney test: *p < 0.05; **p < 0.005,
***p < 0.0005.
(K) Relative abundance plot showing the significantly enriched taxa (log2FC > 2) in fetal Gut as compared to fetal thymus (internal control) and control PBS















































































Figure S3. Plating specificity, efficiency, and reproducibility of fetus-associated bacteria, related to Figure 3
(A) Plate images of serially diluted cultures of fetus-matched tissue inoculates from a separate donor compared tomain Figure 3B (D8), plated under either aerobic
(left) or anaerobic conditions (right). All negative controls (plated as in Figure 3) were clean under both plating conditions, while the colony morphology, color and
size across different plating conditions had notable differences even within the same fetal tissue inoculate.
(B) Plating efficiency (expressed as CFUs/mL) of fetal tissue cultures under aerobic and anaerobic plating conditions across donors and tissues. The area of each
pie chart is proportional to the sum of the CFUs/mL values obtained in the two growth conditions.
(C) Reproducibility of CFU/mL measurements of selected fetus-matched tissue cultures under aerobic and anaerobic plating conditions, between two inde-
pendent culture experiments.
(legend continued on next page)
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(D) Dot-plot showing the distribution of fetal genera present across 7 out of 8 donors which were simultaneously sequenced before (and after) culturing by high-
throughput 16S rRNA sequencing. This analysis is complementary to that in main Figure 3D where the same fetal samples were sequenced after culturing for 48
hours. Mean signal intensity of each genus was calculated and plotted using matplotlib (v.3.2.1) and seaborn (v.0.9.0) Python libraries. For main Figure 3D,
matched PBS were not sequenced post-culturing since there were no detectable colonies in PBS samples. While for pre-culturing, as shown we also sequenced
PBS samples, for comparisons.
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Figure S4. Bacterial structure visualization in fetal gut lumen using scanning electron microscopy, related to Figure 4
(A) Representative SEM images of 14 weeks old EGA fetal mid-gut from three individual fetal samples (n = 3) from multiple fields. Red arrowheads indicate
bacteria-like morphologies within the intestinal lumen. Cocci like bacteria were embedded in the mesh-like mucus covering the intestinal cells. Red arrows
indicate bacteria-like morphologies. (Scale bars = 1 mm)
(B) EM images of 14weeks old fetal foregut (top) and hindgut (bottom) showing themucosal area with bacteria andmucosal area devoid of bacteria from one fetus
(14 weeks EGA). Cocci bacteria (average size of 1 mm) were observed and there were also presence of cocci like bacterial structures found in 14 weeks’ old fetal
foregut and hindgut. Red arrows indicate bacteria-like morphologies. (Scale bars; 10 mm for low magnified views and 1 mm for high magnified views)
(C) SEM images of cultured bacteria (isolated from 18 weeks old fetal Lung) attached on the nitrocellulose membrane. Cocci-like bacterial structures were
prominently seen with an average size of 1 mm. (Scale bar; 1 mm).
(D) Representative image of Hematoxylin & eosin stain (H&E staining) of fetal mid-gut cross-section (isolated from 18 weeks old fetal gut), from serial sections
used for RNA-ISH imaging. The tissue were embedded in FFPE blocks prior to slide preparation. 200 mm magnification.
(E) Representative RNA-ISH imaging (RNAscope) images of fetal liver demonstrating the pan-bacterial probe against bacterial 16S rRNA in green and eukaryotic
epithelial cell marker Epcam specific RNA probe in white. Image on the right shows the merged file. There were no significant spots detected for bacterial 16S
rRNA in fetal liver. Scale bar, 40 mm.
(F) Representative RNA-ISH imaging (RNAscope) images of fetal mesenteric Lymph Nodes (mLN) demonstrating the pan-bacterial probe against bacterial 16S
rRNA in green and eukaryotic epithelial cell marker Epcam specific RNA probe in white. Image on the right shows the merged file. There were no significant spots
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Figure S5. Gating strategy for in vitro syngeneic T cell expansion assay, related to Figure 5
(A) Reference input gating strategy for the Figure 5C, showing the live CD45+ CD3+ T cells gate obtained from fetal mesenteric lymph nodes T cells, post 6 days of
incubationwith the T cells + DC alone, T cells + DCprimedwith fetal Staphylococcus, T cells + DC primedwith fetal Lactobacillus and T cells + CD3/28 dynabeads
respectively (color coded in the figure).
(B) As shown, the CD4/CD8 population frequencies post culturing, and CTV staining, gated on total CD3+ cells from the above panel a.
(C) Another representative flow-cytometry plots for T cell expansion (15 weeks EGA fetal mLN). CellTrace violet (CTV) dye labeled T cells were incubated with
bacteria (fetal Staphylococci and Lactobacilli) primed DC for 6 days. For controls, T cells were incubated with unprimed DC (no bacteria) or CD3/28 dynabeads as
a negative and positive control, respectively. T cell expansion is assayed by measuring dye dilution using flow cytometry. The conditions shown are T cells + DC
alone (gray), T cells + DC primed with fetal staphylococci (blue), T cells + DC primed with fetal lactobacilli (green) and T cells + CD3/28 dynabeads (magenta). For
comparisons, T cell profile at day zero is shown at the left.
(D) CD45RO+ memory T cell expansion post 6 day incubation measured by CD45RO expression and dye dilution (CTVneg) for all the conditions in comparison to
T cell + DC alone (gray). For comparisons, T cell at day zero is shown at the left.
(E) CD69+ activated memory T cell expansion post 6 day incubation measured by CD69 expression and dye dilution (CTVneg) for all the conditions, in comparison
to T cell + DC alone (gray). For comparisons, T cell at day zero is shown at the left.
(F) Levels of TNF released in the culture supernatant of T cells expanded post 6 day exposure to fetal bacteria as determined by drop array-based Luminex assays
(n = 4)
(G) Levels of IFNg released in the culture supernatant of T cells expanded post 6 day exposure to fetal bacteria as determined by drop array-based Luminex
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Figure S6. Flow-cytometry plots for in vitro syngeneic T cell expansion assay (with PFA fixed DC), related to Figure 6
Representative flow cytometry plots of in vitro syngeneic T cell expansion of fetal mLN T cells (treated with bacteria primed DC fixed with 1% PFA) showing the:
(A) frequency of CD4 and CD8 T cells ratio,
(B) CD45RO+ memory T cell plotted against CTV dye to show the dye dilution post 6 days, and
(C) CD69+ activated memory T cell plotted against CTV dye to show the dye dilution post 6 days.
The conditions shown are T cells + fetal staphylococci primed DC (blue), T cells + fetal staphylococci primed PFA fixed DC (orange), T cells + unprimed DC alone
(gray), and T cells + CD3/28 dynabeads (magenta).
Fetal T cell expansion and memory activation assay (with PTI treated DC)
(D) Schematic representation of the syngeneic T cell expansion assay. DC isolated from fetal mLNwere primed with heat-killed fetal bacteria (for 8 hours) followed
by Protein Transport Inhibitor (PTI) treatment (a combination of Monensin and Brefeldin A). PTI treated DC were then presented to CTV labeled T cells from the
same organ (mLN). At day 6, T cell expansion is assayed by dye dilution using flow cytometry.
(E) Representative flow-cytometry histograms for T cell expansion (17 weeks EGA fetal mLN). CellTrace Violet (CTV) dye labeled T cells were incubated with
bacteria (fetal staphylococci) primed DC for 6 days. For controls, T cells were incubated with unprimed DC (no bacteria) or CD3/28 dynabeads as a negative and
positive control, respectively. T cell expansion is assayed by measuring dye dilution using flow cytometry. The conditions shown are T cells + DC alone (gray),
T cells + fetal staphylococci primed DC (blue), T cells + fetal staphylococci primed PTI treated DC (orange) and T cells + CD3/28 dynabeads (magenta).
(F) Total T cell number (absolute count) as counted by CountBright beads, post 6 day incubation, plotted for all the conditions (n = 4). Statistical significance
between experimental groups was determined by paired t test (****p < 0.0001, ***p < 0.001, **p < 0.01)
(G) Frequency of CTVneg expanded memory T cells (CD45RO+, CTVneg) plotted for all conditions.
(H) Frequency of expandedCD69+ activememory T cells (CTVneg) plotted for all conditions. Statistical significance between experimental groups was determined
by two-tailed, unpaired Student’s t test (****p < 0.0001, ***p < 0.001, **p < 0.01)
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